Sandell Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Sandell Asset Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-77,200	Closed	-$8.79M	–	48
2019 Q1	$8.79M	Buy	+77,200	New	+$5.67M	1.56%	15

Sandell Asset Management's ONCE Position: Q4 2019 in Review

Sandell Asset Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 153,000 shares — an estimated $14.8M sold.

Sandell Asset Management first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $43.9M in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Sandell Asset Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Sandell Asset Management sold 153,000 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $14.8M.
Sandell Asset Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
Sandell Asset Management's Spark Therapeutics, Inc. Common Stock position peaked at $43.9M in Q2 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Sandell Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.